J

JW Shinyak Corp
KOSDAQ:067290

Watchlist Manager
JW Shinyak Corp
KOSDAQ:067290
Watchlist
Price: 2 010 KRW -2.43% Market Closed
Market Cap: ₩107.3B

Net Margin

13.4%
Current
Improving
by 19.9%
vs 3-y average of -6.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.4%
=
Net Income
₩10.2B
/
Revenue
₩76B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.4%
=
Net Income
₩10.2B
/
Revenue
₩76B

Peer Comparison

Country Company Market Cap Net
Margin
KR
JW Shinyak Corp
KOSDAQ:067290
112.3B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
270B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
218.4B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.9B EUR
Loading...

Market Distribution

Higher than 87% of companies in Korea
Percentile
87th
Based on 2 632 companies
87th percentile
13.4%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

JW Shinyak Corp
Glance View

Market Cap
107.3B KRW
Industry
Pharmaceuticals

JW SHINYAK Corp. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2003-02-11. The Company’s main products portfolio consists of antibiotics, anesthetics, respiratory remedies, urology remedies, cardiovascular remedies, allergy remedies, digestive remedies, anti-inflammatory drugs, antivirals as well as acne remedies, among others. In addition, it also involves in the provision of cosmetics, such as creams, cleansers, toners, essences, lotions and others.

Intrinsic Value
1 740.14 KRW
Overvaluation 13%
Intrinsic Value
Price
J
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
13.4%
=
Net Income
₩10.2B
/
Revenue
₩76B
What is JW Shinyak Corp's current Net Margin?

The current Net Margin for JW Shinyak Corp is 13.4%, which is above its 3-year median of -6.6%.

How has Net Margin changed over time?

Over the last 3 years, JW Shinyak Corp’s Net Margin has increased from 1.7% to 13.4%. During this period, it reached a low of -35.8% on Dec 31, 2023 and a high of 16.2% on Jun 30, 2025.

Back to Top